GO:0010764 negative regulation of fibroblast migration: Signaling Pathways, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0010764 describes any process that decreases the rate, frequency or extent of fibroblast cell migration, a pseudopodium-driven movement essential in wound healing, fibrosis and cancer.
• Negative regulation of fibroblast migration is achieved by suppressing integrin/FAK, p-AKT/p-ERK and TGF-beta signaling cascades, as shown in skin fibrosis models.
• Cancer-associated fibroblasts (CAFs) can be restrained or reprogrammed; FGFR blockade reduces CAF-mediated immunosuppression and boosts T cell infiltration in triple-negative breast cancer.
• Exosomal microRNAs such as miR-192-5p and miR-3606-3p attenuate fibroblast activation and migration, linking vesicle traffic to GO:0010764.
• Hypoxic CAF-derived exosomal circSTAT3 promotes stemness via miR-671-5p/NOTCH1, illustrating how fibroblast behavior is context-dependently regulated.
• Rheumatoid fibroblast-like synoviocytes are a tractable model for studying negative regulation of fibroblast migration, with YTHDC1 as a key m6A reader controlling migration and invasion.
Description
Fibroblasts are the principal mesenchymal cells responsible for producing and remodeling the extracellular matrix, and their migration is a fundamental component of tissue repair, fibrosis and tumor progression. The Gene Ontology term GO:0010764, negative regulation of fibroblast migration, captures any process that decreases the rate, frequency or extent of fibroblast cell migration, where migration is accomplished by extension and retraction of a pseudopodium. Understanding this term is critical because excessive fibroblast migration drives pathological fibrosis and cancer-associated fibroblast recruitment, whereas insufficient migration impairs wound healing. Recent studies have identified diverse molecular brakes on fibroblast motility, including microRNAs that simultaneously suppress integrin/FAK, p-AKT/p-ERK and TGF-beta cascades, exosomal cargoes that reprogram recipient fibroblasts, and m6A reader proteins that control the migratory machinery of rheumatoid fibroblast-like synoviocytes. In the tumor microenvironment, cancer-associated fibroblasts (CAFs) are a major source of pro-tumorigenic signals, and their negative regulation by FGFR blockade can restore T cell infiltration in triple-negative breast cancer. Hypoxic CAF-derived exosomal circSTAT3 further demonstrates that fibroblast behavior is dynamically regulated by microenvironmental cues. This article synthesizes the authoritative GO definition with verified PubMed literature to provide a research-grade overview of GO:0010764, its mechanisms, key genes, disease relevance and experimental methods.
negative regulation of fibroblast migration At A Glance
| GO ID | GO:0010764 |
|---|---|
| GO term | negative regulation of fibroblast migration |
| Ontology | biological_process |
| Synonym | negative regulation of fibroblast cell migration |
| Definition | Any process that decreases the rate, frequency or extent of fibroblast cell migration. Fibroblast cell migration is accomplished by extension and retraction of a pseudopodium. |
| Major function | Suppression of fibroblast motility, limiting fibrosis, scar formation and tumor-promoting CAF activity |
| Related processes | Regulation of cell migration, wound healing, extracellular matrix remodeling, epithelial-mesenchymal interactions |
| Key signaling pathways | Integrin/FAK, p-AKT/p-ERK, TGF-beta, FGFR, NOTCH1 |
| Disease relevance | Hypertrophic scar, skin fibrosis, rheumatoid arthritis, triple-negative breast cancer |
What Is GO:0010764?
GO:0010764 (negative regulation of fibroblast migration) is a biological process term defined as any process that decreases the rate, frequency or extent of fibroblast cell migration. Fibroblast cell migration itself is accomplished by extension and retraction of a pseudopodium, and the negative regulation can occur through inhibition of signaling pathways, suppression of cytoskeletal dynamics, or changes in gene expression that reduce the migratory capacity of fibroblasts.
Why Is negative regulation of fibroblast migration Important in Cell Biology?
Negative regulation of fibroblast migration is a central control point in tissue homeostasis and disease. When this brake fails, fibroblasts migrate excessively and drive fibrosis, hypertrophic scarring and tumor stroma remodeling; when it is overactive, wound healing is impaired. In cancer, CAFs that escape negative regulation promote immune evasion and stemness, as shown by hypoxic exosomal circSTAT3 signaling in triple-negative breast cancer. Therefore, understanding GO:0010764 provides mechanistic insight into fibrosis, autoimmunity and oncology, and identifies candidate targets for therapeutic intervention.
• Limits pathological fibrosis and hypertrophic scar formation by restraining fibroblast activation and migration.
• Controls cancer-associated fibroblast recruitment and function in the tumor microenvironment.
• Modulates immune cell infiltration indirectly, as FGFR blockade of CAFs boosts T cell infiltration in triple-negative breast cancer.
• Regulates wound healing speed and quality through autophagic and exosomal mechanisms.
• Influences autoimmune joint destruction in rheumatoid arthritis via fibroblast-like synoviocyte migration.
• Provides a mechanistic framework for microRNA-based anti-fibrotic therapeutics.
• Links m6A RNA modification to fibroblast motility through YTHDC1.
• Serves as a biomarker axis for remission in rheumatoid arthritis, with HBEGF+ fibroblasts as a signature population.
• Offers targets for CRISPR knockout, knock-in and overexpression studies to dissect causality.
• Connects exosomal cargo trafficking to fibroblast phenotype switching in hypoxia.
What Happens During negative regulation of fibroblast migration?
Initiation: sensing anti-migratory cues
In simple terms: The fibroblast first receives a stop signal from its environment.
Negative regulation of fibroblast migration begins when fibroblasts encounter anti-migratory cues such as microRNAs, exosomal cargoes or pharmacological inhibitors. For example, miR-3606-3p acts as an integrative suppressor of integrin/FAK, p-AKT/p-ERK and TGF-beta signaling in skin fibrosis, thereby reducing fibroblast migration. Similarly, exosomes from human adipose mesenchymal stem cells deliver miR-192-5p to attenuate hypertrophic scar fibrosis via the IL-17RA/Smad axis. These cues set the stage for downstream cytoskeletal and transcriptional changes that decrease motility.
Signal transduction: suppression of pro-migratory pathways
In simple terms: Inside the cell, the stop signal shuts down the pathways that normally push the cell forward.
Once anti-migratory cues are received, intracellular signaling cascades that normally promote pseudopodial extension are suppressed. Integrin/FAK signaling, p-AKT/p-ERK and TGF-beta cascades are coordinately inhibited by miR-3606-3p, leading to reduced fibroblast migration and activation. In cancer-associated fibroblasts, FGFR blockade alters CAF phenotype and reduces their pro-tumorigenic support, indirectly restraining their migratory and immunosuppressive functions. Autophagic degradation of SQSTM1 is required for fibroblast activation and wound healing, indicating that negative regulation can also occur by interfering with autophagic checkpoints.
Cytoskeletal remodeling: pseudopodium retraction
In simple terms: The cell's front-end protrusions are dismantled, so it cannot crawl.
Fibroblast migration depends on extension and retraction of a pseudopodium. Negative regulation of fibroblast migration ultimately converges on the cytoskeleton, reducing actin-driven protrusion and focal adhesion turnover. Pannexin channels regulate cell migration in immune cells by controlling ATP release and cytoskeletal dynamics, providing a mechanistic template for how membrane channels can modulate migratory machinery. In fibroblasts, suppression of integrin/FAK signaling by miR-3606-3p directly impairs the adhesion turnover required for pseudopodial retraction.
Transcriptional and epigenetic control
In simple terms: Long-term stop signals change which genes the fibroblast expresses.
Sustained negative regulation of fibroblast migration involves transcriptional and epigenetic reprogramming. YTHDC1, an m6A reader, regulates the migration, invasion, proliferation and apoptosis of rheumatoid fibroblast-like synoviocytes, demonstrating that RNA modification machinery controls fibroblast motility programs. Single-cell and bulk RNA sequencing have identified HBEGF+ fibroblasts associated with remission in rheumatoid arthritis, suggesting that specific fibroblast states are transcriptionally wired for reduced migration. Hypoxic CAF-derived exosomal circSTAT3 drives triple-negative breast cancer stemness via miR-671-5p/NOTCH1 signaling, showing that fibroblast-derived vesicles can also modulate neighboring cells and indirectly influence the migratory niche.
Resolution: stable non-migratory phenotype
In simple terms: The fibroblast settles into a less mobile, matrix-remodeling state.
The endpoint of negative regulation of fibroblast migration is a stable reduction in motility, often accompanied by changes in extracellular matrix production and cytokine secretion. Exosomal miR-192-5p from adipose mesenchymal stem cells attenuates hypertrophic scar fibrosis by suppressing IL-17RA/Smad signaling, resulting in a less migratory, less fibrotic fibroblast phenotype. Autophagic degradation of SQSTM1 enables fibroblast activation for wound healing, indicating that the balance between activation and negative regulation determines tissue outcomes. In rheumatoid arthritis, remission is associated with HBEGF+ fibroblasts, a state that may reflect successful negative regulation of migration.
Key Genes Involved in GO:0010764 negative regulation of fibroblast migration
The following genes and non-coding RNAs have been experimentally linked to negative regulation of fibroblast migration or to the fibroblast migration machinery that this GO term controls.
| Gene | Major Role | Research Relevance |
|---|---|---|
| MIR192 | Delivers miR-192-5p from adipose MSC exosomes to suppress IL-17RA/Smad signaling | Attenuates hypertrophic scar fibrosis and fibroblast migration |
| MIR3606 | Encodes miR-3606-3p that integratively suppresses integrin/FAK, p-AKT/p-ERK and TGF-beta | Alleviates skin fibrosis by reducing fibroblast migration |
| IL17RA | Receptor for IL-17; downstream of miR-192-5p regulation | Target of exosomal miR-192-5p in scar fibrosis |
| SMAD | TGF-beta signaling effector family suppressed by miR-192-5p | Mediates anti-fibrotic and anti-migratory effects |
| FGFR | Fibroblast growth factor receptor; blockade alters CAF phenotype | FGFR blockade boosts T cell infiltration in TNBC |
| NOTCH1 | Downstream effector of circSTAT3/miR-671-5p axis | Drives stemness in triple-negative breast cancer |
| STAT3 | Circular RNA circSTAT3 originates from STAT3 locus | Hypoxic CAF exosomal circSTAT3 promotes cancer stemness |
| SQSTM1 | Autophagy receptor whose degradation enables fibroblast activation | Links autophagy to fibroblast activation and wound healing |
| YTHDC1 | m6A reader regulating RNA fate | Controls migration, invasion, proliferation and apoptosis of rheumatoid FLS |
| HBEGF | Heparin-binding EGF-like growth factor | Marker of fibroblast subset in rheumatoid arthritis remission |
| FAK | Focal adhesion kinase; integrin signaling node | Suppressed by miR-3606-3p to reduce migration |
| AKT | Serine/threonine kinase in PI3K pathway | p-AKT suppressed by miR-3606-3p in skin fibrosis |
| ERK | MAP kinase in proliferation/migration signaling | p-ERK suppressed by miR-3606-3p in skin fibrosis |
| TGFB1 | Master pro-fibrotic cytokine | TGF-beta cascade suppressed by miR-3606-3p |
| PANX | Pannexin channel family regulating ATP release and migration | Model for channel-mediated control of cell migration |
| MIR671 | Encodes miR-671-5p targeting NOTCH1 | Mediates circSTAT3-driven stemness in TNBC |
How Is negative regulation of fibroblast migration Regulated?
Negative regulation of fibroblast migration is controlled at multiple levels. At the post-transcriptional level, microRNAs such as miR-3606-3p and miR-192-5p coordinately suppress integrin/FAK, p-AKT/p-ERK, TGF-beta and IL-17RA/Smad signaling, thereby reducing fibroblast motility. At the RNA modification level, the m6A reader YTHDC1 regulates migration, invasion, proliferation and apoptosis of rheumatoid fibroblast-like synoviocytes, linking epitranscriptomic control to fibroblast behavior. At the protein degradation level, autophagic degradation of SQSTM1 is required for fibroblast activation, indicating that autophagy acts as a checkpoint for the migratory/activated state. At the intercellular level, exosomal cargoes from cancer-associated fibroblasts, including circSTAT3, can modulate recipient cells via miR-671-5p/NOTCH1 signaling, indirectly shaping the migratory niche. Pharmacological blockade of FGFR can also reprogram CAFs and alter their functional output in the tumor microenvironment.
negative regulation of fibroblast migration and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| MIR192 | Hypertrophic scar fibrosis | Adipose MSC exosome delivery in fibroblast cultures and scar models |
| MIR3606 | Skin fibrosis | miR-3606-3p mimic/inhibitor in dermal fibroblasts |
| FGFR | Triple-negative breast cancer | FGFR inhibitor treatment in CAF-tumor co-cultures and mouse models |
| STAT3/circSTAT3 | TNBC stemness | Hypoxic CAF exosome transfer to cancer cells |
| YTHDC1 | Rheumatoid arthritis | Knockdown or knockout in rheumatoid fibroblast-like synoviocytes |
| SQSTM1 | Wound healing | Autophagy inhibition or SQSTM1 knockout in fibroblasts |
Fibrosis and hypertrophic scar
Excessive fibroblast migration and activation underlie hypertrophic scar and skin fibrosis. Exosomes from human adipose mesenchymal stem cells attenuate hypertrophic scar fibrosis by delivering miR-192-5p to suppress IL-17RA/Smad signaling, providing a therapeutic strategy that enhances negative regulation of fibroblast migration. Similarly, miR-3606-3p alleviates skin fibrosis by integratively suppressing integrin/FAK, p-AKT/p-ERK and TGF-beta cascades, directly reducing fibroblast migration and activation. These studies establish GO:0010764 as a protective axis in fibrotic skin disease.
Triple-negative breast cancer and the tumor microenvironment
Cancer-associated fibroblasts promote tumor progression, immune evasion and stemness. FGFR blockade boosts T cell infiltration into triple-negative breast cancer by regulating CAFs, demonstrating that restraining CAF function can remodel the immune microenvironment. Hypoxic CAF-derived exosomal circSTAT3 drives triple-negative breast cancer stemness via miR-671-5p/NOTCH1 signaling, illustrating how fibroblast-derived vesicles can amplify malignancy. Thus, negative regulation of fibroblast migration and CAF activity is a therapeutic goal in TNBC.
Rheumatoid arthritis
Rheumatoid fibroblast-like synoviocytes exhibit invasive, migratory behavior that contributes to joint destruction. YTHDC1 regulates the migration, invasion, proliferation and apoptosis of rheumatoid fibroblast-like synoviocytes, identifying an m6A-dependent control point. Single-cell and bulk RNA sequencing have identified HBEGF+ fibroblasts in the remission of rheumatoid arthritis, suggesting that specific fibroblast states are associated with disease control. Enhancing negative regulation of fibroblast migration may therefore promote remission in RA.
Wound healing
Autophagic degradation of SQSTM1 enables fibroblast activation to accelerate wound healing, indicating that negative regulation of fibroblast migration must be transient and reversible for proper repair. Excessive or prolonged negative regulation could impair wound closure, whereas insufficient negative regulation could lead to fibrosis. This balance makes GO:0010764 a key node in regenerative medicine.
From negative regulation of fibroblast migration-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of a candidate gene enhance fibroblast migration? | CRISPR knockout in primary dermal or synovial fibroblasts |
| Does a specific point mutation in a signaling node alter anti-migratory signaling? | Point-mutation knock-in in fibroblast cell lines |
| Does overexpression of a microRNA reduce fibroblast migration? | Lentiviral overexpression of miR-3606-3p or miR-192-5p |
| Does tagging an m6A reader affect its function in fibroblast motility? | Tagged knock-in of YTHDC1 in rheumatoid FLS |
| Does exosomal cargo transfer regulate recipient fibroblast behavior? | Exosome isolation and transfer from CAFs or MSCs |
| Does FGFR blockade reprogram CAFs in vivo? | Syngeneic or xenograft TNBC models with FGFR inhibitor |
How to Study the negative regulation of fibroblast migration Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Scratch wound assay | Rate of fibroblast monolayer closure | Testing anti-migratory microRNAs or drugs |
| Transwell migration | Number of cells migrating through a membrane | Quantifying negative regulation of fibroblast migration |
| Single-cell RNA-seq | Fibroblast subset composition and states | Identifying remission-associated fibroblasts in RA |
| Bulk RNA-seq | Global transcriptional changes | Nominating pathways suppressed by anti-migratory cues |
| Exosome transfer | Functional cargo delivery between cells | Testing miR-192-5p or circSTAT3 effects |
| Western blot | Phospho-protein levels (p-FAK, p-AKT, p-ERK) | Confirming pathway suppression |
| Autophagy flux assay | LC3-II and SQSTM1 turnover | Linking autophagy to fibroblast activation |
| Immunofluorescence | Cytoskeletal and focal adhesion morphology | Visualizing pseudopodium retraction |
Transcriptomic profiling of fibroblast states
Single-cell RNA sequencing and bulk RNA sequencing have been used to identify fibroblast subsets such as HBEGF+ fibroblasts in rheumatoid arthritis remission, providing a discovery platform for genes that enforce negative regulation of fibroblast migration. Differential expression analysis can nominate microRNAs and m6A regulators for functional follow-up.
Functional migration assays
Scratch wound, transwell and live-cell imaging assays quantify the rate and extent of fibroblast migration after genetic or pharmacological perturbation. These assays are the direct readout for GO:0010764 and have been applied to test miR-3606-3p, miR-192-5p and FGFR blockade.
Exosome and vesicle biology
Exosome isolation, characterization and transfer experiments reveal how fibroblast-derived or MSC-derived vesicles deliver microRNAs and circular RNAs that modulate migration. This approach has been used for miR-192-5p from adipose MSCs and circSTAT3 from hypoxic CAFs.
Autophagy and protein degradation assays
LC3 flux, SQSTM1 turnover and autophagy inhibition experiments define how autophagic degradation of SQSTM1 controls fibroblast activation and wound healing, linking protein homeostasis to GO:0010764.
How CRISPR Can Be Used to Study GO:0010764 negative regulation of fibroblast migration
Knockout
CRISPR knockout of candidate negative regulators such as YTHDC1 or SQSTM1 in fibroblasts can test whether loss of function increases migration, directly probing GO:0010764. Knockout of microRNA loci or their targets can also reveal epistatic relationships in the integrin/FAK and TGF-beta cascades.
Point Mutation
Point-mutation knock-in can dissect phosphorylation sites or binding residues in signaling nodes such as FAK, AKT or ERK, determining which specific residues are required for anti-migratory signaling. This approach complements pathway-level inhibition studies.
Knock-in
Tagged knock-in of YTHDC1 or other m6A readers enables tracking of RNA-protein interactions and localization in rheumatoid fibroblast-like synoviocytes, linking epitranscriptomic regulation to migration phenotypes. Knock-in of reporter cassettes under microRNA-responsive promoters can also quantify negative regulation of fibroblast migration in real time.
Overexpression
Overexpression of miR-3606-3p or miR-192-5p in fibroblasts suppresses integrin/FAK, p-AKT/p-ERK, TGF-beta and IL-17RA/Smad signaling, reducing migration and fibrosis in vitro and in vivo. Overexpression of circSTAT3 in hypoxic CAFs, conversely, promotes stemness in recipient cancer cells, illustrating context-dependent effects.
How EDITGENE Supports negative regulation of fibroblast migration Research
Researchers studying negative regulation of fibroblast migration-related genes often need to determine whether a candidate gene is causally involved in suppressing or promoting fibroblast motility. EDITGENE provides end-to-end CRISPR services to generate precisely engineered cell models that answer these questions.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of fibroblast migration research.
Frequently Asked Questions About negative regulation of fibroblast migration
What is negative regulation of fibroblast migration (GO:0010764)?
It is any process that decreases the rate, frequency or extent of fibroblast cell migration, where migration is accomplished by extension and retraction of a pseudopodium.
What genes are involved in negative regulation of fibroblast migration?
Key genes include MIR3606, MIR192, IL17RA, SMAD, FGFR, NOTCH1, STAT3, SQSTM1, YTHDC1, HBEGF, FAK, AKT, ERK and TGFB1.
How do microRNAs suppress fibroblast migration?
miR-3606-3p integratively suppresses integrin/FAK, p-AKT/p-ERK and TGF-beta cascades, while miR-192-5p suppresses IL-17RA/Smad signaling, both reducing fibroblast migration.
What role do exosomes play in fibroblast migration?
Exosomes from adipose MSCs deliver miR-192-5p to attenuate scar fibrosis, and hypoxic CAF exosomes deliver circSTAT3 to promote cancer stemness via miR-671-5p/NOTCH1.
How is fibroblast migration regulated in rheumatoid arthritis?
YTHDC1 regulates migration, invasion, proliferation and apoptosis of rheumatoid fibroblast-like synoviocytes, and HBEGF+ fibroblasts are associated with remission.
Can FGFR blockade affect cancer-associated fibroblasts?
Yes, FGFR blockade boosts T cell infiltration into triple-negative breast cancer by regulating cancer-associated fibroblasts.
What is the role of autophagy in fibroblast activation?
Autophagic degradation of SQSTM1 enables fibroblast activation to accelerate wound healing, linking autophagy to the migratory/activated state.
Which signaling pathways are suppressed during negative regulation of fibroblast migration?
Integrin/FAK, p-AKT/p-ERK, TGF-beta and IL-17RA/Smad pathways are commonly suppressed.
What experimental models are used to study GO:0010764?
Scratch wound and transwell assays, single-cell RNA-seq, exosome transfer, autophagy flux assays and CRISPR knockout/knock-in models are widely used.
How can CRISPR help study negative regulation of fibroblast migration?
CRISPR knockout, point mutation, knock-in and overexpression models allow causal testing of candidate genes in fibroblast motility and related diseases.
Conclusion
GO:0010764, negative regulation of fibroblast migration, is a biologically and clinically important process that restrains fibroblast motility through microRNA-mediated suppression of integrin/FAK, p-AKT/p-ERK, TGF-beta and IL-17RA/Smad signaling, epitranscriptomic control by YTHDC1, and autophagic checkpoints such as SQSTM1. Its dysregulation contributes to hypertrophic scar, skin fibrosis, rheumatoid arthritis and triple-negative breast cancer, making it a rich source of therapeutic targets. CRISPR-based knockout, point-mutation, knock-in and overexpression models, combined with exosome and single-cell approaches, provide the tools needed to dissect this process and translate findings into new treatments.
References
- 1. Yang L et al.. 2025. Hypoxic cancer-associated fibroblast exosomal circSTAT3 drives triple negative breast cancer stemness via miR-671-5p/NOTCH1 signaling.. J Transl Med 23(1):814 PMID: 40702555
- 2. Xu Y et al.. 2025. Autophagic degradation of SQSTM1 enables fibroblast activation to accelerate wound healing.. Autophagy 21(11):2401-2421 PMID: 40400126
- 3. Li Y et al.. 2021. Exosomes derived from human adipose mesenchymal stem cells attenuate hypertrophic scar fibrosis by miR-192-5p/IL-17RA/Smad axis.. Stem Cell Res Ther 12(1):221 PMID: 33789737
- 4. Wu Y et al.. 2022. FGFR blockade boosts T cell infiltration into triple-negative breast cancer by regulating cancer-associated fibroblasts.. Theranostics 12(10):4564-4580 PMID: 35832090
- 5. Harcha PA et al.. 2021. Pannexin Channel Regulation of Cell Migration: Focus on Immune Cells.. Front Immunol 12:750480 PMID: 34975840
- 6. Chen Y et al.. 2025. miR-3606-3p alleviates skin fibrosis by integratively suppressing the integrin/FAK, p-AKT/p-ERK, and TGF-β signaling cascades.. J Adv Res 75:271-290 PMID: 39571732
- 7. Feng ZW et al.. 2024. YTHDC1 Regulates the Migration, Invasion, Proliferation, and Apoptosis of Rheumatoid Fibroblast-Like Synoviocytes.. Front Immunol 15:1440398 PMID: 39534605
- 8. Chen N et al.. 2022. Identification of HBEGF+ fibroblasts in the remission of rheumatoid arthritis by integrating single-cell RNA sequencing datasets and bulk RNA sequencing datasets.. Arthritis Res Ther 24(1):215 PMID: 36068607
